News

1/13/2023
A new clinical trial offered at Providence Cancer Institute to study the safety and effectiveness of two different treatments for people under age 70 with previously untreated non-GCB DLBCL.
12/20/2022
Providence Cancer Institute highlights a year of engaging with and supporting our patients, partner organizations and community.
12/9/2022
Under guidance from the Oregon Health Authority, we have activated crisis standards of care in some care areas at Providence Oregon hospitals.
12/8/2022
Many emergency rooms, clinics and urgent care centers are experiencing a sharp rise in the number of cases of RSV, flu and COVID.
12/6/2022
Providence Cancer Institute is offering a phase III trial for patients with gynecologic cancers and two early phase trials that will study new medications in treating solid tumors.
12/3/2022
Providence is seeing many children with RSV. Under guidance from OHA, we have activated crisis standards of care in pediatric units at Providence Portland Medical Center.
12/12/2022
Bernard A. Fox, Ph.D., leader of the Laboratory of Molecular and Tumor Immunology honored by the Society for Immunotherapy of Cancer for legacy of public service.
11/23/2022
Providence is seeing many children with RSV. Under guidance from OHA, we have activated crisis standards of care in pediatric units at Providence St. Vincent Medical Center.
11/18/2022
A joint statement from Kaiser Permanente, Legacy Health, OHSU Health and Providence
11/23/2022
Providence Cancer Institute to hold two virtual events on the benefits of integrative medicine for patients.
11/7/2022
Providence Cancer Institute one of only a few sites worldwide offering two new clinical trials for solid tumors and lung cancer.
10/17/2022
Learn about some changes that will be taking place at the Center for Medically Fragile Children, with an expansion of adult intermediate care.